This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Boujrad, N. Articles by Papadopoulos, V. Search for Related Content PubMed PubMed Citation Articles by Boujrad, N. Articles by Papadopoulos, V.

The Peroxisome Proliferator Perfluorodecanoic Acid Inhibits the Peripheral-Type Benzodiazepine Receptor (PBR) Expression and Hormone-Stimulated Mitochondrial Cholesterol Transport and Steroid Formation in Leydig Cells¹

Division of Hormone Research, Departments of Cell Biology, Pharmacology & Neuroscience, Georgetown University Medical Center, Washington, DC 20007

Address all correspondence and requests for reprints to: Vassilios Papadopoulos, Georgetown University Medical Center, Department of Cell Biology, 3900 Reservoir Road, Northwest, Washington, D.C. 20007. E-mail: papadopv{at}gunet.georgetown.edu

The peroxisome proliferator perfluordecanoic acid (PFDA) has been shown to exert an antiandrogenic effect in vivo by acting directly on the interstitial Leydig cells of the testis. The objective of this study was to examine the in vitro effects of PFDA and identify its site of action in steroidogenesis using as model systems the mouse tumor MA-10 and isolated rat Leydig cells. PFDA inhibited in a time- and dose-dependent manner the hCG-stimulated Leydig cell steroidogenesis. This effect was localized at the level of cholesterol transport into the mitochondria. PFDA did not affect either the total cell protein synthesis or the mitochondrial integrity. Moreover, it did not induce any DNA damage. Morphological studies indicated that PFDA induced lipid accumulation in the cells, probably due to the fact that cholesterol mobilized by hCG did not enter the mitochondria to be used for steroidogenesis. In search of the target of PFDA, we examined its effect on key regulatory mechanisms of steroidogenesis. PFDA did not affect the hCG-induced steroidogenic acute regulatory protein (StAR) levels. However, it was found to inhibit the mitochondrial peripheral-type benzodiazepine receptor (PBR) ligand binding capacity, 18-kDa protein, and messenger RNA (mRNA) levels. Further studies indicated that PFDA did not affect PBR transcription, but it rather accelerated PBR mRNA decay. Taken together, these data suggest that PFDA inhibits the Leydig cell steroidogenesis by affecting PBR mRNA stability, thus inhibiting PBR expression, cholesterol transport into the mitochondria, and the subsequent steroid formation. Moreover, this action of PFDA on PBR mRNA stability indicates a new mechanism of action of peroxisome proliferators distinct from the classic transcription-mediated regulation of target genes.

This article has been cited by other articles:

				S.-Y. Zhang, Y. Ito, O. Yamanoshita, Y. Yanagiba, M. Kobayashi, K. Taya, C. Li, A. Okamura, M. Miyata, J. Ueyama, et al. Permethrin May Disrupt Testosterone Biosynthesis via Mitochondrial Membrane Damage of Leydig Cells in Adult Male Mouse Endocrinology, August 1, 2007; 148(8): 3941 - 3949. [Abstract] [Full Text] [PDF]

				Z. Shi, H. Zhang, Y. Liu, M. Xu, and J. Dai Alterations in Gene Expression and Testosterone Synthesis in the Testes of Male Rats Exposed to Perfluorododecanoic Acid Toxicol. Sci., July 1, 2007; 98(1): 206 - 215. [Abstract] [Full Text] [PDF]

				A. Gravel and M. M. Vijayan Salicylate Disrupts Interrenal Steroidogenesis and Brain Glucocorticoid Receptor Expression in Rainbow Trout Toxicol. Sci., September 1, 2006; 93(1): 41 - 49. [Abstract] [Full Text] [PDF]

				M. Gazouli, Z.-X. Yao, N. Boujrad, J. C. Corton, M. Culty, and V. Papadopoulos Effect of Peroxisome Proliferators on Leydig Cell Peripheral-Type Benzodiazepine Receptor Gene Expression, Hormone-Stimulated Cholesterol Transport, and Steroidogenesis: Role of the Peroxisome Proliferator-Activator Receptor {alpha} Endocrinology, July 1, 2002; 143(7): 2571 - 2583. [Abstract] [Full Text] [PDF]